Prot# WX17801: A Prospective, Rndmzd, Dbl-Blind, Active Cntrlld, Parallel Group, Multi-Center Trial to Assess the Efficacy & Safety of Mycophenolate Mofetil (MMF) in Inducing Response & Maintaining Remission in Sbjts w/Lupus Nephritis {ALMS}

Project: Research project

Project Details

StatusFinished
Effective start/end date10/28/0510/26/10

Funding

  • PPD Development (WX17801)
  • Aspreva Pharmaceuticals Corporation (WX17801)